Jonathan Yingling

发表

Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice.

Iñaki F Trocóniz, Sophie Glatt, J. Yingling, 2008, European journal of cancer.